Whalesbook
📉 The Financial Deep Dive: Simplex Castings Q3 FY26 Performance
Simplex Castings Ltd. has disclosed its financial results for the third quarter and nine months ended December 31, 2025, revealing a mixed performance. While the nine-month period showcased robust top-line expansion, the third quarter presented significant headwinds for profitability.
Quarterly Performance (Q3 FY26 vs Q3 FY25):
The company registered a marginal 0.8% year-on-year decrease in revenue from operations, falling to ₹4,753.31 Lakhs from ₹4,791.84 Lakhs. Profit After Tax (PAT) saw a more substantial decline of 24.3% YoY, reaching ₹476.09 Lakhs compared to ₹629.12 Lakhs in the previous year. Consequently, Earnings Per Share (EPS) dropped 27.6% YoY to ₹6.33 from ₹8.74.
Sequential Performance (Q3 FY26 vs Q2 FY26):
On a sequential basis, the performance was also weaker. Revenue declined by 14.2% from ₹5,540.97 Lakhs to ₹4,753.31 Lakhs. PAT fell by 14.7% sequentially from ₹557.77 Lakhs to ₹476.09 Lakhs, with EPS decreasing to ₹6.33 from ₹7.42.
Nine-Month Performance (9MFY26 vs 9MFY25):
The outlook for the longer term appears more promising, with the nine-month period demonstrating strong growth. Revenue surged by 41.3% YoY to ₹14,814.01 Lakhs, up from ₹10,478.75 Lakhs. PAT grew by 30.6% YoY to ₹1,507.61 Lakhs, and EPS rose by 25.0% YoY to ₹20.05.
Notable Accounting Item:
An important disclosure is that the 'Other Income' for Q3 FY26 included ₹153.02 Lakhs from interest accrued on the LIC Gratuity Fund, pertaining to earlier financial years. This prior period item significantly bolstered the reported 'Other Income' and, by extension, the PAT for the quarter, masking a potentially sharper decline in operational profitability.
Fundraising Exercise:
The Board of Directors has approved a proposal to raise up to ₹50.15 Crores by issuing equity shares on a preferential basis. The shares will be issued at a premium of ₹484 per share, setting the issue price at ₹494 (face value ₹10). This move, subject to shareholder and regulatory approvals, signals a capital infusion strategy, likely to fuel growth or manage debt, though it will result in shareholder dilution.
Outlook and Discussion:
This announcement does not provide any forward-looking guidance from the management regarding future growth drivers, market outlook, or specific business strategies. Investors will need to await further commentary or analyst calls for such insights.
Risks & Outlook:
The primary risks highlighted by the Q3 results include a sequential downturn in revenue and profitability, suggesting potential demand slowdowns or execution challenges. The reliance on prior period income to boost quarterly results warrants scrutiny. The preferential issue, while providing capital, introduces dilution risk for existing shareholders. The company's ability to translate its strong nine-month performance into sustained quarterly growth will be key.